Guru Ownership Trend
Guru Analysis for ARS Pharmaceuticals, Inc. (SPRY)
ARS Pharmaceuticals, Inc. (SPRY), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $6.34 M.
Top institutional holders include Daniel Loeb and Chuck Royce.
Institutional sentiment is currently Bullish. This is evidenced by a $7.41 M net inflow during the quarter.
Recent activity highlights Daniel Loeb who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for ARS Pharmaceuticals, Inc. (SPRY)
Major holders include Daniel Loeb ($6.48 M), Chuck Royce ($2.41 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 763,288 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $7.41 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited SPRY. The total reported sell value was $1.48 M.
Yes, 2 managers opened new positions in SPRY, and 0 increased their existing holdings. The total reported buy value was $8.89 M.